- Home
- BRAG vs ELOX Comparison
BRAG vs ELOX Comparison
Compare BRAG & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRAG | ELOX |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Canada | United States |
| Employees | N/A | 7 |
| Industry | Office Equipment/Supplies/Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 41.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRAG | ELOX |
|---|---|---|
| Price | $1.62 | $17.62 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 27.1K | ★ 55.5K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $10.00 |
| 52 Week High | $4.20 | $19.36 |
Technical Indicators
Market Signals| Indicator | BRAG | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 67.66 |
| Support Level | $1.52 | $10.74 |
| Resistance Level | $1.90 | $19.36 |
| Average True Range (ATR) | 0.15 | 2.00 |
| MACD | 0.00 | 0.72 |
| Stochastic Oscillator | 46.74 | 80.34 |
Price Performance
Historical ComparisonAbout BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.
About ELOX Eloxx Pharmaceuticals Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.